LONDON (Reuters) - A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results